BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21310273)

  • 1. Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect.
    Senderek J; Müller JS; Dusl M; Strom TM; Guergueltcheva V; Diepolder I; Laval SH; Maxwell S; Cossins J; Krause S; Muelas N; Vilchez JJ; Colomer J; Mallebrera CJ; Nascimento A; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Steinlein OK; Schlotter B; Schoser B; Kirschner J; Herrmann R; Voit T; Oldfors A; Lindbergh C; Urtizberea A; von der Hagen M; Hübner A; Palace J; Bushby K; Straub V; Beeson D; Abicht A; Lochmüller H
    Am J Hum Genet; 2011 Feb; 88(2):162-72. PubMed ID: 21310273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1).
    Chen Q; Müller JS; Pang PC; Laval SH; Haslam SM; Lochmüller H; Dell A
    Biomolecules; 2015 Oct; 5(4):2758-81. PubMed ID: 26501342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in GFPT1 that underlie limb-girdle congenital myasthenic syndrome result in reduced cell-surface expression of muscle AChR.
    Zoltowska K; Webster R; Finlayson S; Maxwell S; Cossins J; Müller J; Lochmüller H; Beeson D
    Hum Mol Genet; 2013 Jul; 22(14):2905-13. PubMed ID: 23569079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.
    Bauché S; Vellieux G; Sternberg D; Fontenille MJ; De Bruyckere E; Davoine CS; Brochier G; Messéant J; Wolf L; Fardeau M; Lacène E; Romero N; Koenig J; Fournier E; Hantaï D; Streichenberger N; Manel V; Lacour A; Nadaj-Pakleza A; Sukno S; Bouhour F; Laforêt P; Fontaine B; Strochlic L; Eymard B; Chevessier F; Stojkovic T; Nicole S
    J Neurol; 2017 Aug; 264(8):1791-1803. PubMed ID: 28712002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limb-girdle myasthenia with tubular aggregates associated with novel GFPT1 mutations.
    Huh SY; Kim HS; Jang HJ; Park YE; Kim DS
    Muscle Nerve; 2012 Oct; 46(4):600-4. PubMed ID: 22987706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice.
    Issop Y; Hathazi D; Khan MM; Rudolf R; Weis J; Spendiff S; Slater CR; Roos A; Lochmüller H
    Hum Mol Genet; 2018 Sep; 27(18):3218-3232. PubMed ID: 29905857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
    Guergueltcheva V; Müller JS; Dusl M; Senderek J; Oldfors A; Lindbergh C; Maxwell S; Colomer J; Mallebrera CJ; Nascimento A; Vilchez JJ; Muelas N; Kirschner J; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Schlotter B; Schoser B; Herrmann R; Voit T; Steinlein OK; Najafi A; Urtizberea A; Soler DM; Muntoni F; Hanna MG; Chaouch A; Straub V; Bushby K; Palace J; Beeson D; Abicht A; Lochmüller H
    J Neurol; 2012 May; 259(5):838-50. PubMed ID: 21975507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome sequencing detection of two untranslated GFPT1 mutations in a family with limb-girdle myasthenia.
    Maselli RA; Arredondo J; Nguyen J; Lara M; Ng F; Ngo M; Pham JM; Yi Q; Stajich JM; McDonald K; Hauser MA; Wollmann RL
    Clin Genet; 2014 Feb; 85(2):166-71. PubMed ID: 23488891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3'-UTR mutation creates a microRNA target site in the GFPT1 gene of patients with congenital myasthenic syndrome.
    Dusl M; Senderek J; Müller JS; Vogel JG; Pertl A; Stucka R; Lochmüller H; David R; Abicht A
    Hum Mol Genet; 2015 Jun; 24(12):3418-26. PubMed ID: 25765662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dok-7 promotes slow muscle integrity as well as neuromuscular junction formation in a zebrafish model of congenital myasthenic syndromes.
    Müller JS; Jepson CD; Laval SH; Bushby K; Straub V; Lochmüller H
    Hum Mol Genet; 2010 May; 19(9):1726-40. PubMed ID: 20147321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel compound heterozygous variants in the GFPT1 gene leading to rare limb-girdle congenital myasthenic syndrome with rimmed vacuoles.
    Ma Y; Xiong T; Lei G; Ding J; Yang R; Li Z; Guo J; Shen D
    Neurol Sci; 2021 Aug; 42(8):3485-3490. PubMed ID: 33438142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukoencephalopathy due to variants in
    Helman G; Sharma S; Crawford J; Patra B; Jain P; Bent SJ; Urtizberea JA; Saran RK; Taft RJ; van der Knaap MS; Simons C
    Neurology; 2019 Feb; 92(6):e587-e593. PubMed ID: 30635494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
    Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
    Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies.
    Belaya K; Rodríguez Cruz PM; Liu WW; Maxwell S; McGowan S; Farrugia ME; Petty R; Walls TJ; Sedghi M; Basiri K; Yue WW; Sarkozy A; Bertoli M; Pitt M; Kennett R; Schaefer A; Bushby K; Parton M; Lochmüller H; Palace J; Muntoni F; Beeson D
    Brain; 2015 Sep; 138(Pt 9):2493-504. PubMed ID: 26133662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
    Belaya K; Finlayson S; Slater CR; Cossins J; Liu WW; Maxwell S; McGowan SJ; Maslau S; Twigg SR; Walls TJ; Pascual Pascual SI; Palace J; Beeson D
    Am J Hum Genet; 2012 Jul; 91(1):193-201. PubMed ID: 22742743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dok-7 mutations underlie a neuromuscular junction synaptopathy.
    Beeson D; Higuchi O; Palace J; Cossins J; Spearman H; Maxwell S; Newsom-Davis J; Burke G; Fawcett P; Motomura M; Müller JS; Lochmüller H; Slater C; Vincent A; Yamanashi Y
    Science; 2006 Sep; 313(5795):1975-8. PubMed ID: 16917026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse myopathological features in the congenital myasthenia syndrome with GFPT1 mutation.
    Jiang K; Zheng Y; Lin J; Wu X; Yu Y; Zhu M; Fang X; Zhou M; Li X; Hong D
    Brain Behav; 2022 Feb; 12(2):e2469. PubMed ID: 34978387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very late-onset limb-girdle congenital myasthenic syndrome due to GFPT1 mutation.
    El-Wahsh S; Wijesinghe R; Qiu J; Heard R; Stoll M; Reddel S
    Muscle Nerve; 2023 Sep; 68(3):E32-E34. PubMed ID: 37403580
    [No Abstract]   [Full Text] [Related]  

  • 19. Congenital myasthenic syndromes due to mutations in ALG2 and ALG14.
    Cossins J; Belaya K; Hicks D; Salih MA; Finlayson S; Carboni N; Liu WW; Maxwell S; Zoltowska K; Farsani GT; Laval S; Seidhamed MZ; ; Donnelly P; Bentley D; McGowan SJ; Müller J; Palace J; Lochmüller H; Beeson D
    Brain; 2013 Mar; 136(Pt 3):944-56. PubMed ID: 23404334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A valid mouse model of AGRIN-associated congenital myasthenic syndrome.
    Bogdanik LP; Burgess RW
    Hum Mol Genet; 2011 Dec; 20(23):4617-33. PubMed ID: 21890498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.